多发性硬化临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 多发性硬化（国际通用名 multiple sclerosis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖MS等说法。

正在招募的多发性硬化新药试验

• The Swedish BioFINDER 2 Study

  不适用招募中SwedenNCT03174938

• Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

  I 期招募中美国NCT07221240

• Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

  不适用招募中美国NCT07392879

• Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)

  不适用招募中法国NCT06280742

• Home Based Infusions for Ocrelizumab

  IV 期招募中美国NCT04650321

• Role of Genetic Factors in the Development of Lung Disease

  不适用招募中美国NCT00001532

• Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  II 期招募中美国NCT02521311

• A Palliative Care Model Impact on Knowledge and Attitudes

  不适用招募中美国NCT06860932

• Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

  不适用招募中美国NCT04933552

• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

  III 期招募中NetherlandsNCT05834855

• Gait Adaptability in Persons With MS Having Mild Disability

  不适用招募中BelgiumNCT07580820

• Implementation of an App-based Walking Aid Skills Training Program

  不适用招募中加拿大NCT05347875